Loading organizations...
§ Private Profile · Cambridge, MA, USA
Health technology company capturing home-reported outcomes for patients with chronic and complex illnesses and clinical research.
Based in Cambridge, Massachusetts, Folia Health is a health technology company that develops a platform for capturing home-reported patient outcomes to support personalized clinical care and medical research. The software enables individuals managing chronic and complex illnesses, such as immunodeficiency disorders, to track daily symptoms and treatments. Through a data dividend model, the enterprise compensates users for sharing de-identified health metrics with pharmaceutical companies and healthcare institutions conducting clinical trials. Following a funding round closed in early 2024, the firm continues to expand its research programs across the broader medical sector. The company's leadership maintains active involvement in regional healthcare initiatives, holding positions within the Massachusetts Women in Digital Health network, the Digital Health Council Working Group, and the Independent Steering Committee. Folia Health was founded in 2016 by Nell Meosky Luo and Dan Toffling.
Folia Health has raised $105.0M across 1 funding round.
Folia Health has raised $105.0M in total across 1 funding round.
Folia Health has raised $105.0M in total across 1 funding round.
Folia Health's investors include Grayhawk Capital, S3 Ventures, Create Health Ventures, Crosslink Capital.
Folia Health has raised $105.0M across 1 funding round. Most recently, it raised $105.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2025 | $105M Series A | Grayhawk Capital, S3 Ventures | Create Health Ventures, Crosslink Capital | Announced |